Time to Next Treatment Within 24 Months (TTNT24) as a Predictor of Survival in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia: A Population-Based Observational Study.
Sign Up to like & getrecommendations! Published in 2025 at "European journal of haematology"
DOI: 10.1111/ejh.70073
Abstract: INTRODUCTION Prognostic models in Waldenström's macroglobulinemia (WM) are typically static, baseline tools applied before treatment initiation and do not account for dynamic post-treatment factors. We evaluated time to next treatment within 24 months (TTNT24), as a… read more here.
Keywords: months ttnt24; treatment; waldenstr macroglobulinemia; treatment within ... See more keywords